Join
Live feed
·
INSIDERFilingvia Quantisnow
Hepion Pharmaceuticals Inc. logo

Interim CEO Stetz Gary S. bought $50,000 worth of shares (1,250,000 units at $0.04) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
HEPA· Hepion Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HEPA (Hepion Pharmaceuticals Inc.) and more on Quantisnow.